Quantcast
Viewing all articles
Browse latest Browse all 18762

Elan, Biogen change terms of Tysabri collaboration

Thursday, February 7, 2013

Biogen Idec will take over full ownership of the multiple sclerosis treatment Tysabri from its partner Irish drugmaker Elan Corp.


Viewing all articles
Browse latest Browse all 18762

Trending Articles